TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25305156

Group type: EXPERIMENTAL
Intervention: PiB+ (β‐amyloid deposition)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Small hippocampal volume
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: WML volume
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Combination of imaging abnormalities (PiB+, small hippocampi, WMLs)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Continuous variables of PiB retention, left and right hippocampal volume, and WML volume
Number of subjects: 183
Study: 22228285

Group type: EXPERIMENTAL
Intervention: Virtual patient trainer
Number of subjects: 93

Group type: COMPARATOR
Intervention: Traditional lecture
Number of subjects: 93
Study: 20164311

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention
Number of subjects: 2730

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention in diabetic white women
Number of subjects: 2730

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention in diabetic black women
Number of subjects: 2730
Study: 16550311

Group type: COMPARATOR
Intervention: Standard dose bolus of tirofiban (10 microg/kg/3 min) with 24‐h infusion at a rate of 0.15 microg/kg/min
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Single high-dose bolus tirofiban (25 microg/kg/3 min)
Number of subjects: 100
Study: 15157751

Group type: EXPERIMENTAL
Intervention: Mental stress (laboratory speech stressor task)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Mood assessment (Hamilton Rating Scales for Depression and Anxiety)
Number of subjects: 48
Study: 10932083

Group type: EXPERIMENTAL
Intervention: Double-blind placebo-controlled food challenge (DBPCFC) with celery
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Open provocation with celery
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CAP method for specific IgE determination
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Skin prick tests (SPTs) with commercial extracts
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Prick-to-prick tests with crude celery
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SPT and CAP tests
Number of subjects: 32
Study: 9305603

Group type: EXPERIMENTAL
Intervention: St Jude-type multiagent chemotherapy
Number of subjects: 23

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: St Jude-type multiagent chemotherapy (for good-prognosis subgroup)
Number of subjects: 23
Study: 8361895

Group type: EXPERIMENTAL
Intervention: Molsidomine (2 mg, single oral dose)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 2423807

Group type: EXPERIMENTAL
Intervention: Indoramin alone (n = 58)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Indoramin plus thiazide diuretic (n = 157)
Number of subjects: 215
Study: 31975638

Group type: EXPERIMENTAL
Intervention: Elastic band group (Theraband®)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Elastic tubes training using Lemgruber® (ETG)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional training with weight machine equipment (CG)
Number of subjects: 48
Study: 31999484

Group type: EXPERIMENTAL
Intervention: Pickup trucks transporting people in the cargo area
Number of subjects: 4611

Group type: EXPERIMENTAL
Intervention: León
Number of subjects: 4611

Group type: EXPERIMENTAL
Intervention: Cuernavaca
Number of subjects: 4611

Group type: EXPERIMENTAL
Intervention: Guadalajara‐Zapopan
Number of subjects: 4611

Group type: EXPERIMENTAL
Intervention: Male drivers not using seatbelt correctly
Number of subjects: 4611
Study: 30621749

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Remifentanil (REMI)
Number of subjects: 94
Study: 28592188

Group type: EXPERIMENTAL
Intervention: SEC-coated CPB circuit
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-coated CPB circuit
Number of subjects: 12
Study: 26072289

Group type: EXPERIMENTAL
Intervention: 18 months androgen suppression (AS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiation dose escalation (RDE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dose rate brachytherapy boost (HDRB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (6 months AS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-radiation urethral strictures
Number of subjects: 0
Study: 23419410

Group type: EXPERIMENTAL
Intervention: High perfectionistic rearing behaviors
Number of subjects: 77

Group type: COMPARATOR
Intervention: Non-perfectionistic rearing behaviors
Number of subjects: 77
Study: 21643673

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Reserpine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 18789492

Group type: EXPERIMENTAL
Intervention: JTT‐705 600 mg/d
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 17365206

Group type: EXPERIMENTAL
Intervention: Group A (pharmacists trained in asthma education)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group B (pharmacist researcher trained as asthma educator)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group C (usual care by community pharmacists)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group A (MDI technique)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group B (MDI technique)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group A (DPI technique)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group B (DPI technique)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group C (inhaler technique)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group A and B (asthma knowledge scores)
Number of subjects: 48
Study: 16305570

Group type: EXPERIMENTAL
Intervention: Self-administered isoflurane and desflurane
Number of subjects: 396

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396
Study: 12028976

Group type: EXPERIMENTAL
Intervention: Physiotherapist delivered intervention (training in pelvic floor exercises and strategies to improve adherence)
Number of subjects: 676

Group type: COMPARATOR
Intervention: Usual postpartum care
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Physiotherapist delivered intervention
Number of subjects: 676
Study: 9708557

Group type: EXPERIMENTAL
Intervention: Uptake of oxidized vitamin C (dehydroascorbic acid) via GLUT1 into erythrocytes
Number of subjects: 2
Study: 7607764

Group type: EXPERIMENTAL
Intervention: Thrombolysis (pre-hospital)
Number of subjects: 1516

Group type: EXPERIMENTAL
Intervention: Thrombolysis (hospital)
Number of subjects: 1516

Group type: EXPERIMENTAL
Intervention: Thrombolysis (total)
Number of subjects: 1516

Group type: EXPERIMENTAL
Intervention: Resuscitation
Number of subjects: 1516

Group type: EXPERIMENTAL
Intervention: Thrombolysis (GREAT trial)
Number of subjects: 1516

Group type: EXPERIMENTAL
Intervention: Thrombolysis (overall)
Number of subjects: 1516

Group type: EXPERIMENTAL
Intervention: Cardiac arrest (hospital patients)
Number of subjects: 1516
Study: 2225366

Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) program
Number of subjects: 8012

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 8012
Study: 352974

Group type: EXPERIMENTAL
Intervention: melperone (Buronil)
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60

Group type: COMPARATOR
Intervention: melperone (Buronil) vs placebo
Number of subjects: 60
Study: 31175903

Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Transarterial Chemoembolization (TACE)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT) for recurrent HCC
Number of subjects: 188
Study: 28068365

Group type: EXPERIMENTAL
Intervention: Ocular Response Analyzer (ORA)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Goldmann Applanation Tonometry (GAT)
Number of subjects: 66
Study: 25530364

Group type: EXPERIMENTAL
Intervention: Silodosin (group B)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Tamsulosin (group A)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Tadalafil (group C)
Number of subjects: 285
Study: 23985260

Group type: EXPERIMENTAL
Intervention: Trastuzumab plus chemotherapy (FP/H)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Chemotherapy alone (FP)
Number of subjects: 85
Study: 21624637

Group type: EXPERIMENTAL
Intervention: Ultraviolet light disinfection of keyboards
Number of subjects: 0
Study: 19417992

Group type: EXPERIMENTAL
Intervention: Essential oil-containing mouthrinse
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 82
Study: 16650294

Group type: EXPERIMENTAL
Intervention: Intrarectal application of 2% lidocaine gel
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Periprostatic anesthesia
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intravenous injection of midazolam and meperidine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no sedation or analgesic)
Number of subjects: 160
Study: 15499296

Group type: COMPARATOR
Intervention: LR-RIT alone
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: LR-RIT + TMZ
Number of subjects: 73
Study: 11530870

Group type: EXPERIMENTAL
Intervention: Dexamethasone (24 mg divided into 4 doses 12 hours apart)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 139
Study: 11367651

Group type: EXPERIMENTAL
Intervention: Qingning Oral Liquid (QNOL) with conventional therapy, 10 ml three times a day for 30 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 40
Study: 8150234

Group type: EXPERIMENTAL
Intervention: Cholecystokinin-33 infusion (0.25 Ivy Dog Unit.kg‐1.h‐1) during hyperglycaemia
Number of subjects: 14

Group type: COMPARATOR
Intervention: Cholecystokinin-33 infusion (0.5 Ivy Dog Unit.kg‐1.h‐1) during hyperglycaemia
Number of subjects: 14

Group type: COMPARATOR
Intervention: Cholecystokinin-33 infusion (1.0 Ivy Dog Unit.kg‐1.h‐1) during hyperglycaemia
Number of subjects: 14
Study: 2605963

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-carotene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1148091

Group type: EXPERIMENTAL
Intervention: Intercostal nerve blocks with lignocaine
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Intercostal nerve blocks with bupivacaine
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control (no nerve block)
Number of subjects: 138
Study: 30170956

Group type: EXPERIMENTAL
Intervention: DBP-mesalamine (high exposure)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-DBP mesalamine (background exposure)
Number of subjects: 70
Study: 28717811

Group type: EXPERIMENTAL
Intervention: Individually-tailored nutrition plan with 3 telephone contacts and 1 home visit over 3 months (n = 52)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (n = 48)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Quality of life and appetite measures
Number of subjects: 100
Study: 26566122

Group type: EXPERIMENTAL
Intervention: Lemongrass oil hair tonic at 5%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lemongrass oil hair tonic at 10%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lemongrass oil hair tonic at 15%
Number of subjects: 30
Study: 22617307

Group type: EXPERIMENTAL
Intervention: Antibiotics + Proxelan for 28 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Antibiotics for 28 days
Number of subjects: 60
Study: 19863515

Group type: EXPERIMENTAL
Intervention: Single exposure to DNCB 60 microg cm(‐2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Three repeated exposures to DNCB 10 microg cm(‐2)
Number of subjects: 20
Study: 18544384

Group type: EXPERIMENTAL
Intervention: Local wound infusion of 0.15% bupivacaine at 2 mL/h combined with intravenous patient-controlled analgesia
Number of subjects: 38

Group type: COMPARATOR
Intervention: Intravenous patient-controlled analgesia alone with sham thoracotomy wound infusion of normal saline
Number of subjects: 38
Study: 15793092

Group type: EXPERIMENTAL
Intervention: High tech softball bats with polyurethane softballs
Number of subjects: 7

Group type: COMPARATOR
Intervention: Recommended safety standards
Number of subjects: 7
Study: 12221310

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Enhanced Vocational Rehabilitation (EVR)
Number of subjects: 150
Study: 9988841

Group type: COMPARATOR
Intervention: New antipsychotics (risperidone, olanzapine, sertindole, quetiapine)
Number of subjects: 2477

Group type: COMPARATOR
Intervention: Sertindole and quetiapine
Number of subjects: 2477

Group type: COMPARATOR
Intervention: Risperidone and olanzapine
Number of subjects: 2477

Group type: COMPARATOR
Intervention: All new antipsychotics
Number of subjects: 2477

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 2477

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 2477
Study: 7734250

Group type: EXPERIMENTAL
Intervention: Weight-corrected group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Standard dose group
Number of subjects: 48
Study: 2341772

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iontophoresis
Number of subjects: 0
Study: 6785797

Group type: EXPERIMENTAL
Intervention: (-)deprenyl
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31590924

Group type: EXPERIMENTAL
Intervention: FAAH inhibitor (PF‐04457845, 4 mg orally, once daily)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 30935551

Group type: EXPERIMENTAL
Intervention: Soft inflatable rubber ball (SIRB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hard massage ball (HMB)
Number of subjects: 30
Study: 27940278

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (2 L/min via standard nasal prongs) during the 6-min walk test (6MWTO2)
Number of subjects: 124
Study: 25661195

Group type: EXPERIMENTAL
Intervention: MK-7123 (30 mg, po, daily for 28 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 23417515

Group type: EXPERIMENTAL
Intervention: Ziprasidone 60 mg twice daily
Number of subjects: 12
Study: 21795435

Group type: EXPERIMENTAL
Intervention: Glucose infusion (0.12 g · kg(‐1) · h(‐1))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Glucose infusion
Number of subjects: 20
Study: 19376588

Group type: EXPERIMENTAL
Intervention: Oral diclofenac
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Topical diclofenac
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 17324660

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba-based supplement (160 mg ginkgo biloba, 68 mg gotu kola, and 180 mg DHA per day for 4 months)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 16442038

Group type: EXPERIMENTAL
Intervention: Onion extract gel (Mederma) applied three times daily for 8 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Petrolatum-based emollient (Aquaphor) applied three times daily for 8 weeks
Number of subjects: 24
Study: 14673717

Group type: EXPERIMENTAL
Intervention: Instrumented anterior lumbar interbody fusion (ALIF)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Instrumented circumferential fusion with PLIF
Number of subjects: 74
Study: 11232592

Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol (500 IU/day, 8 days)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 9034695

Group type: EXPERIMENTAL
Intervention: Right unilateral (RUL) electroconvulsive therapy (ECT)
Number of subjects: 20
Study: 1355427

Group type: EXPERIMENTAL
Intervention: cetirizine 10 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: loratadine 10 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: alcohol (0.72 g.kg‐1, lean body mass)
Number of subjects: 16
Study: 6438504

Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Intracoronary nitroglycerin
Number of subjects: 124

Group type: COMPARATOR
Intervention: Conventional therapy without initial angiography
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Subtotal obstruction
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: All four groups
Number of subjects: 124
Study: 31618346

Group type: EXPERIMENTAL
Intervention: Ventilator hyperinflation (5 minutes in pressure-controlled ventilation mode, increasing pressure by 5cmH2O to a maximum of 35cmH2O)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Ventilator hyperinflation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control condition (without changes in the parameters)
Number of subjects: 38
Study: 30703315

Group type: EXPERIMENTAL
Intervention: Revised consent form template
Number of subjects: 153

Group type: COMPARATOR
Intervention: Original consent form template
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Knowledge about trials before reviewing consent forms
Number of subjects: 153

Group type: COMPARATOR
Intervention: Revised and Original consent forms
Number of subjects: 153
Study: 25628006

Group type: EXPERIMENTAL
Intervention: JDTic 1 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: JDTic
Number of subjects: 12

Group type: COMPARATOR
Intervention: JDTic and Placebo
Number of subjects: 12
Study: 23433414

Group type: COMPARATOR
Intervention: CT angiography
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: MR angiography
Number of subjects: 19
Study: 21731145

Group type: EXPERIMENTAL
Intervention: Nasal mask
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oronasal mask
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nasal mask and Oronasal mask
Number of subjects: 24
Study: 19372326

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 66

Group type: COMPARATOR
Intervention: Landmark-based technique
Number of subjects: 66
Study: 16885722

Group type: EXPERIMENTAL
Intervention: Single 10 mg oral dose of dronabinol (synthetic THC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Multiple oral doses of THC (0.39, 0.47, and 14.8 mg THC in hemp oil and 7.5 mg dronabinol)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both models combined
Number of subjects: 18
Study: 15595301

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) 0.2 g Cr x kg(‐1) after exercise
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Creatine (Cr)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 22
Study: 11902516

Group type: EXPERIMENTAL
Intervention: Participation in the European Randomised Study on Screening for Prostate Cancer
Number of subjects: 75000
Study: 9404202

Group type: EXPERIMENTAL
Intervention: Golytely
Number of subjects: 102

Group type: COMPARATOR
Intervention: Citromag
Number of subjects: 102
Study: 8390732

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD) with polymyxin E, tobramycin, and amphotericin B enterally and by oropharyngeal swab for 6 +/- 4 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group receiving perioperative parenteral antibiotics only
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 36
Study: 2427448

Group type: EXPERIMENTAL
Intervention: 3% HES 200/0.5
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control groups (not specified)
Number of subjects: 55
Study: 31664632

Group type: EXPERIMENTAL
Intervention: 80% Aloe Vera gel
Number of subjects: 140

Group type: COMPARATOR
Intervention: 0.12% Chlorhexidine gel
Number of subjects: 140
Study: 30581291

Group type: EXPERIMENTAL
Intervention: Dopamine (DA)-blocking drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28958469

Group type: EXPERIMENTAL
Intervention: Lenalidomide (2.5 mg/day)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo (2.5 mg/day)
Number of subjects: 314
Study: 26340002

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural analgesia (CSEA)
Number of subjects: 285
Study: 24734355

Group type: EXPERIMENTAL
Intervention: 6 hours Chlorhexidine (CHX) 0.5% oral decontamination
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 12 hours Chlorhexidine (CHX) 0.5% oral decontamination
Number of subjects: 30
Study: 22014804

Group type: EXPERIMENTAL
Intervention: Doppler guided fluid
Number of subjects: 66
Study: 18000094

Group type: EXPERIMENTAL
Intervention: 50 mg daily of micronized DHEA
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 17095898

Group type: EXPERIMENTAL
Intervention: Topiramate alone
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Topiramate plus nitrazepam and/or valproate
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Topiramate (average dosage 5.2 mg/kg per day)
Number of subjects: 54
Study: 12907482

Group type: EXPERIMENTAL
Intervention: Heroin plus methadone (maximum 1000 mg heroin per day and 150 mg methadone per day)
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Injectable heroin plus methadone (maximum 1000 mg heroin per day and 150 mg methadone per day)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Methadone alone (maximum 150 mg per day)
Number of subjects: 549
Study: 12796135

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 389

Group type: COMPARATOR
Intervention: No HRT
Number of subjects: 389
Study: 10766402

Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization (TMR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Angioplasty and coronary artery bypass grafting
Number of subjects: 0
Study: 8682597

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 60-90 mg o.d.
Number of subjects: 339

Group type: COMPARATOR
Intervention: Isosorbide dinitrate 40-60 mg b.d.
Number of subjects: 339

Group type: COMPARATOR
Intervention: Isosorbide mononitrate 50-100 mg o.d.
Number of subjects: 339
Study: 1992535

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (320 to 1,600 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0